问题 › 我的业务实际价值是多少？ › 会计与咨询事务所
估值主要取决于所有权变更后有多少收益能留存，而非43.2m收入规模。 会计事务所面临的问题版本不同。合规收费压缩、无法在不减少法定产出的前提下将工时转向咨询，因此忽略82%实现率的答案必然错误。分析必须从71%计费利用率和34%咨询成交率出发，而非从收入出发。
估值主要取决于所有权变更后有多少收益能留存，而非43.2m收入规模。 会计事务所面临的问题版本不同。合规收费压缩、无法在不减少法定产出的前提下将工时转向咨询，因此忽略82%实现率的答案必然错误。分析必须从71%计费利用率和34%咨询成交率出发，而非从收入出发。
管理合伙人往往把估值视为利润乘数。买方则判断有多少利润能在其所有权下存续，因此两家收益相同的公司售价可能大相径庭。
驱动因素固定：合规业务收入集中度、从法定产出转向咨询的比例、对管理合伙人客户关系的依赖程度，以及实现率与计费利用率下的毛利率表现。这些因素对乘数的影响大于利润每增加一个点。
因此实际问题通常不是“值多少钱”，而是“哪一项压低了乘数，以及能否在出售前修复”。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 你查看在产品报告，发现实现率卡在82%，且未针对客户集中度调整。
✓ 计费工时显示管理合伙人每月仍承担最大份额的关键合规客户关系。
✓ 咨询成交率34%，合规客户留存率91%，利用率71%。
通常会让情况更糟的做法。 在出售前一年优化实现率，却未触及乘数驱动因素，通常带来的价值低于修复其中一项。
It is for you if you run or finance an accounting firm and you are within a few years of a transaction and have never had the earnings normalised. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家会计事务所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For 会计事务所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
行业区间容易找到，却最不实用。你落在区间哪一端，取决于集中度、复购性、所有者依赖度和利润防御力。
若目标是提升乘数，需要两到三年，因为 recurring revenue 和降低所有者依赖需要时间才能在数字中显现。
取决于买方。财务买家为 durable cash flow 付费；战略买家为业务对其自身位置的影响付费。清楚你面对哪类买方，会改变需修复的内容。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית